A randomized controlled study to assess the efficacy of topical Sinecathechins used as adjuvant therapy to topical ablative trichloroacetic acid in the Treatment of anal High grade squamous intraepithelial lesion

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519782-21-00

Acronym

SINECHSIL

Enrollment

150

Registered

2025-03-24

Start date

2025-09-18

Completion date

Unknown

Last updated

2025-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal high-grade squamous intraepithelial lesions (HSIL).

Brief summary

Cumulative proportion of patients free of HSIL at 48 weeks post-treatment (with an allowed deviation of 8 weeks).

Interventions

DRUGSINECATECHINS

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Cumulative proportion of patients free of HSIL at 48 weeks post-treatment (with an allowed deviation of 8 weeks).	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026